2586 Organometallics, Vol. 26, No. 10, 2007
Yamada et al.
analyses were performed by using a PE2400II Series (Perkin-Elmer
Co.). Some analytical runs were performed twice to confirm the
reproducibility in the independent analysis/synthesis runs.
127.0, 128.8, 135.8, 162.3, 165.3, 198.8. 51V NMR (CDCl3): δ
-153 (∆ν1/2 ) 1817 Hz). Anal. Calcd for C24H35N2OV: C, 68.88;
H, 8.43; N, 6.69. Found: C, 68.62; H, 8.36; N, 6.44.
Synthesis of VMe(N-2,6-Me2C6H3)(NCtBu2)(OC6F5) (2d). Syn-
thesis of 2d was carried out according to the same procedure as
that in 2a except that C6F5OH (92 mg, 0.50 mmol) was used in
place of 2,6-Me2C6H2OH. Yield: 202 mg (79%). 1H NMR
(CDCl3): δ 1.31 (s, 18H, (CH3)3C-), 1.49 (3H, V-CH3), 2.42 (s,
6H, CH3), 6.79 (t, 1H), 6.90 (d, 3H). 13C NMR (CDCl3): δ 18.7,
30.3, 43.1 (br, V-Me), 45.6, 125.1, 127.1, 133.4, 135.8, 136.6, 138.5,
139.1, 139.9, 140.9, 163.7, 203.9. 19F NMR (CDCl3): δ -171.64,
-167.13, -160.94. 51V NMR (CDCl3): δ -98 (∆ν1/2 ) 295 Hz).
1
All H, 13C, and 51V NMR spectra were recorded on a JEOL
1
JNM-LA400 spectrometer (399.65 MHz for H, 100.40 MHz for
13C, and 105.31 MHz for 51V), and 19F NMR spectra were recorded
on a JEOL JNM-ECP600NK spectrometer (564.69 MHz for 19F).
All spectra were obtained in the solvent indicated at 25 °C unless
otherwise noted. Chemical shifts are given in ppm and are
1
referenced to SiMe4 (δ 0.00, H, 13C), CF3C6H5 (δ -64.0, 19F),
H3PO4 (δ 0.00, 31P), and VOCl3 (δ 0.00, 51V). Coupling constants
and half-width values, ∆ν1/2, are given in Hz.
Synthesis of VMe(N-2,6-Me2C6H3)(NCtBu2)(OiPr) (2e). Syn-
thesis of 2e was carried out by the same procedure as that in 2a
except that iPrOH (48 mg, 0.80 mmol) was used in place of phenol.
One-Pot Synthesis of VMe(N-2,6-Me2C6H3)(NdCtBu2)2 (1).
To an Et2O solution (60 mL) containing VCl3(N-2,6-Me2C6H3)
(1.38 g, 5.0 mmol) was added LiNdCtBu2 (1.55 g, 10.5 mmol) at
-30 °C. The reaction mixture was warmed slowly to room
temperature (25 °C), and the mixture was stirred for an additional
6 h. MeMgBr (3.0 M in Et2O, 1.83 mL) was then added dropwise
to the reaction mixture that had been at -30 °C. The mixture was
then warmed slowly to room temperature and was stirred for an
additional 4 h. The solution was then placed in a rotary evaporator
in Vacuo to remove solvent (hexane, Et2O), and the resultant residue
was extracted with hot n-hexane (ca. 100 mL). The n-hexane extract
was then placed in Vacuo, and the resultant residue was layered by
n-hexane (ca. 10 mL) at -30 °C. The chilled solution was placed
1
Yield: 286 mg (93%). H NMR (CDCl3): δ 1.03 (3H, V-CH3),
1.28 (s, 18H, (CH3)3C-), 1.28 (d, 6H, (CH3)2CH-), 2.52 (s, 6H,
CH3), 4.87 (hept, 1H, (CH3)2CH-), 6.70 (t, 1H), 6.92 (d, 2H). 13
C
NMR (CDCl3): δ 19.3, 26.9, 30.5, 35.0 (br V-Me), 44.8, 77.6,
123.0, 127.0, 134.2, 161.8, 198.8. 51V NMR (CDCl3): δ -244
(∆ν1/2 ) 311 Hz).
Synthesis of VMe(N-2,6-Me2C6H3)(NCtBu2)(OCH2CH2CHd
CH2) (2f). Synthesis of 2f was carried out according to the same
procedure as that in 2a except that 3-butene-1-ol (30 mg, 0.42
mmol) was used in place of 4-tBu-2,6-iPr2C6H2OH. Yield: 137 mg
(86%). 1H NMR (CDCl3): δ 1.15 (s, br, 3H, V-CH3), 1.27 (s, 18H,
(CH3)3C-), 2.62 (2H, OCH2CH2), 2.62 [s, 6H, (CH3)2], 4.55 (2H),
4.75-4.86 (2H), 5.56 (1H), 6.76 (t, 1H), 6.93 (d, 2H). 13C NMR
(CDCl3): δ 14.2, 19.4, 22.6, 30.6, 31.6, 39.3, 42.6, 45.0, 45.6, 75.2,
116.4, 123.5, 127.3, 134.7, 137.3, 158.1, 185.8. 51V NMR
(CDCl3): δ -103 (∆ν1/2 ) 1632 Hz), -231 (∆ν1/2 ) 579 Hz).
Anal. Calcd for C22H37N2OV: C, 66.64; H, 9.41; N, 7.07. Found:
C, 66.95; H, 9.70; N, 6.76.
1
in the freezer to give red microcrystals. Yield: 1.35 g (58%). H
NMR (CDCl3): δ 0.88 (br, 3H, V-CH3), 1.31 (s, 18H, (CH3)3C-
), 2.44 (s, 6H, CH3), 6.67 (t, 1H), 6.86 (d, 2H). 13C NMR (CDCl3):
δ 19.4, 30.8, 36.7, 45.6, 122.2, 126.8, 134.1, 162.7, 199.4. 51V NMR
(CDCl3):
δ -138.8 (∆ν1/2 ) 324 Hz). Anal. Calcd for
C27H48N3V: C, 69.64; H, 10.39; N, 9.03. Found: C, 69.16; H,
10.14; N, 9.09.
Synthesis of VMe(N-2,6-Me2C6H3)(NCtBu2)(O-2,6-Me2C6H3)
(2a). To a n-hexane solution (10 mL) containing 1 (372 mg, 0.80
mmol) was added 2,6-Me2C6H2OH (98 mg, 0.80 mmol) at
-30 °C. The reaction mixture was warmed slowly to room
temperature and was stirred for an additional 3 h. The solution was
concentrated in Vacuo, and the chilled solution (-30 °C) yielded
t
SynthesisofVMe(N-2,6-Me2C6H3)(NCBu2)(OCH2CH2CH2CH2CHd
CH2) (2g). Synthesis of 2g was carried out by the same procedure
as that in 2a except that 5-hexene-1-ol (20 mg, 0.20 mmol) was
used. Yield: 56 mg (66%). 1H NMR (CDCl3 at 20 °C): δ 1.07 (s,
br, 3H, V-CH3), 1.25 (s, 18H, (CH3)3C-), 1.41 (2H), 1.71 (2H),
1.97 (2H), 2.53 (s, 6H, CH3), 4.52 (2H), 4.89-4.94 (2H), 5.71 (1H),
6.74 (t, 1H), 6.91 (d, 2H). 13C NMR (CDCl3 at 20 °C): δ 14.1,
19.4, 22.6, 25.0, 30.5, 31.6, 33.6, 34.2, 42.2, 44.9, 76.3, 114.2,
123.4, 127.2, 134.6-137.2, 138.9, 159.7, 185.4, 198.8. 51V NMR
(CDCl3 at 20 °C): δ -105 (∆ν1/2 ) 1685 Hz), -237 (∆ν1/2 ) 527
Hz). Anal. Calcd for C24H41N2OV: C, 67.90; H, 9.73; N, 6.60.
Found: C, 67.97; H, 9.88; N, 6.62.
1
335 mg (94%) of 2a as red microcrystals. H NMR (CDCl3): δ
1.34 (3H, V-CH3), 1.41 (s, 18H, (CH3)3C-), 2.33 (s, 6H, CH3),
2.47 (s, 6H, CH3), 6.81 (m, 2H), 6.96 (d, 2H), 7.03 (d, 2H). 13C
NMR (CDCl3): δ 17.6, 18.9, 30.5, 38.5 (br, V-Me), 45.4, 120.4,
123.9, 126.8, 127.1, 128.0, 162.8, 163.87, 201.3. 51V NMR
(CDCl3): δ -185 (∆ν1/2 ) 253 Hz). Anal. Calcd for C26H39N2-
OV: C, 69.93; H, 8.80; N, 6.27. Found: C, 70.02; H, 8.98; N, 6.20.
Synthesis of VMe(N-2,6-Me2C6H3)(NCtBu2)(O-4-tBu-2,6-
iPr2C6H2) (2b). Synthesis of 2b was carried out according to the
same procedure as that in 2a except that 4-tBu-2,6-iPr2C6H2OH
(47 mg, 0.20 mmol) was used in place of 2,6-Me2C6H2OH. Yield:
Reaction of 1 with n-Hexanol: Synthesis of V(N-2,6-Me2C6H3)-
(NCtBu2)[OCH2(CH2)4CH3]. The synthesis was carried out by the
same procedure as that in 2a except that n-hexanol (42 mg, 0.41
mmol) was used. 1H NMR (CDCl3): δ 0.82 (3H), 1.04 (s, br, 3H,
V-CH3), 1.23 (s, 18H, (CH3)3C-), 1.25-1.28 (m, 6H), 1.66 (2H),
2.51 (s, 6H, CH3), 4.50 (2H), 6.73 (t, 1H), 6.90 (d, 2H). 51V NMR
(CDCl3): δ -238 (∆ν1/2 ) 419 Hz).
1
104 mg (93%). H NMR (CDCl3): δ 1.18 (d, 12H, Me2CH-),
1.34 (s, 9H, para-(CH3)3C), 1.37 (s, 18H, (CH3)3C), 2.52 (s, 6H,
CH3), 3.56 (hept, 2H, Me2CH-), 6.79 (t, 1H), 6.94 (d, 2H), 7.08
(s, 2H). The V-Me signal was not found due to a peak over-
V(N-2,6-Me2C6H3)(NdCtBu2)(S-2,6-Me2C6H3) (3a). To an n-
hexane solution (10 mL) containing 1 (186 mg, 0.40 mmol) was
added 2,6-Me2C6H3SH (57 mg, 0.41 mmol) at -30 °C. The reaction
mixture was warmed slowly to room temperature (25 °C) and was
stirred for an additional 3 h. The solution was concentrated in Vacuo,
and the chilled solution (-30 °C) yielded 176 mg (75%) of 3a as
lapping with tBu groups in both aryloxo and ketimide ligands. 13
C
NMR (CDCl3): δ 19.1, 23.2, 23.4, 26.8, 30.5, 31.7, 34.6, 38.3
(br, V-Me), 45.2, 119.5, 123.6, 127.0, 134.5, 136.5, 143.3, 158.1,
162.5, 200.7. 51V NMR (CDCl3): δ -197 (∆ν1/2 ) 284 Hz).
Anal. Calcd for C34H55N2OV: C, 73.08; H, 9.92; N, 5.01. Found
(1): C, 72.98; H, 10.14; N, 4.99. Found (2): C, 73.14; H, 9.72;
N, 5.11.
1
brown crystals. H NMR (CDCl3): δ 1.22 (s, 36H, (CH3)3C-),
2.39 (s, 6H, CH3), 2.51 (s, 6H, CH3), 6.73 (t, 1H), 6.83 (t, 1H),
6.88 (d, 2H), 6.92 (d, 2H). 13C NMR (CDCl3): δ 19.1, 23.9, 30.4,
45.2, 123.6, 124.4, 126.8, 126.9, 134.4, 139.5, 144.6, 163.3, 198.5.
51V NMR (CDCl3): δ -132 (∆ν1/2 ) 341 Hz).
Synthesis of VMe(N-2,6-Me2C6H3)(NCtBu2)(OPh) (2c). Syn-
thesis of 2c was carried out according to the same procedure as
that in 2a except that PhOH (39 mg, 0.41 mmol) was used in place
1
of 2,6-Me2C6H2OH. Yield: 154 mg (92%). H NMR (CDCl3): δ
Reaction of 1 with n-C6H13SH (3b). To a NMR tube equipped
with a Teflon (Young) valve containing a C6D6 solution
(0.5 mL) of 1 (47 mg, 0.1 mmol) was added n-C6H13SH (12 mg,
0.1 mmol) at room temperature (25 °C). Three sets of resonances
1.30 (s, 18H, (CH3)3C-), 1.43 (3H, V-CH3), 2.45 (s, 6H, CH3),
6.77 (t, 1H), 6.89 (d, 3H), 7.04 (d, 2H), 7.19 (t, 2H). 13C NMR
(CDCl3): δ 19.1, 30.4, 39.7 (br, V-Me), 45.0, 119.3, 121.0, 124.0,